2 High-Yield Stocks to Buy in October (Hint: Bristol Myers Squibb Is One)
If you are looking for yield and can think long-term, you'll want to consider Bristol Myers Squibb and Realty Income today.
Overview
As October gets underway, the S&P 500 index (SNPINDEX: ^GSPC) is trading near all-time highs and offering a tiny little 1% dividend yield. That means that Bristol Myers Squibb (NYSE: BMY) is offering a yield more than 4x larger, while Realty Income's (NYSE: O) is roughly 6x larger. If you are looking for high-yield stocks to buy in October, both should sound very enticing. Here's a quick look at each one.
Bristol Myers Squibb traces its birth back to the late 1800s. It has a long and successful history in the pharmaceutical sector. However, the sector is highly competitive, and there's an important nuance regarding new drugs: they receive patent exclusivity for only a short period. New drugs can generate huge profits, but only for a brief period. So, drug makers are always on the lookout for new blockbuster drugs to offset patent losses.
Image source: Getty Images.
Details
Source
Originally published at www.fool.com.
Related Articles
- Jensen Huang Said Nvidia Now Has "a Lot Greater Visibility" Into Demand, Letting It Forecast a Full Year Ahead for the First Time Ever. Does That Confidence Justify Nvidia's Premium Valuation?
- This Colorado Springs Hotel Has Its Own Flight Simulators
- Think You Missed Out on Nvidia's Stock Rise? Think Again.